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Abstract
The objective of the study – is to identify the age peculiarities of the fat-acidic and lipid blood plasma spectrum
in the inhabitants of the plain settlements of the Transcarpathian region with overweight and obesity.
Materials and methods. There were examined 107 persons, who applied for the assistance to the Family
Medicine Outpatient Clinic #7 in Uzhgorod. The examined persons were estimated the following data: age,
gender, BMI, waist circumference, lipid and fat-acidic spectrum.
Results of the study. The study involved 74 women (69.1%) and 33 men (30.9%). The average age of the
examined persons was 52.4±1.0 years. The BMI of the examined patients was 27.5±0.4 kg/m2, and the waist
circumference was – 92.4±1.6 cm. All patients were divided into 6 age groups with intervals of 5 years, starting
with 40 years. Starting from the 46 years and older, in each age group, there was a significantly higher BMI
compared to persons under 40 years of age. In the examined persons over 40 years the changes of the lipid
spectrum in the direction of growth of atherogenic fractions were observed.
Beginning from the age of 46 years, the levels of total ω6-PUFA and ω3-PUFA are significantly higher compared
to persons aged under 40 years. In individuals aged under 50 years there is an increase of average levels of
PUFA, therefore the highest growth of ω3-PUFAs is observed in the period from 40 to 50 years of age (from
60.10±5.50 µg/ml to 102.9±5.20 µg/ml, p< 0.01), and of ω6-PUFA in the period from 45 to 50 years (from
1288.10±62.40 µg/ml to 1501.10±67.50 µg/ml; p=0.03).
Conclusions. There is a shift in the lipid spectrum, which corresponds to atherogenic dyslipidemia, in the
examined persons aged over 40 years. In individuals aged under 50 years there is an increase in total levels of
PUFA, thus the highest growth of ω3-PUFA is observed in the period from 40 to 50 years, and ω6- PUFA in the
period from 45 to 50 years. The stabilization of the fatty acids composition was revealed in persons aged 50
years and more.
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Problem statement and analysis of
the latest research
Obesity is a topical problem, not only because of the
pandemic extent of distribution, but also because it
is one of the risk factors for the development of a
number of cardiovascular diseases, metabolic syn-
drome (MS), type 2 diabetes mellitus (DM), Pick-
wickian syndrome and some oncological nosologies.
The detection of the peculiarities of metabolic pro-
cesses at the level of lipid and fat-acidic metabolism,
depending on the body mass index and age, is one
of the directions of the author’s work.
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According to the meta-analysis of six prospec-
tive cohort studies (31096 patients with a follow-
up period of 5.9 to 17.7 years), elevated levels of
eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA) were associated with a decreased risk
of cardiovascular events [1, 2]. After the studies
of Dyerberg [3] and Kagawa [4], who noted the
protective effect of eicosapentaenoic acid on car-
diovascular diseases, a large number of studies has
been performed to evaluate the effect of fatty acids
(FA) on the profile of lipoproteins and the effect
on cardiovascular risk (CVR). Reviews made by
Chowdhury [5] and Michas [6] summarized the ex-
isting view of the association between individual
FA, groups of fatty acids and CVR. Polyunsatu-
rated fatty acids (PUFAs), especially ω3-PUFAs,
according to Kelley [7] and Ninomiya [8], can re-
duce CVR, while saturated and monounsaturated
FA can increase CVR. Similarly, certain subclasses
of lipoproteins, in particular, small particles of LDL,
are associated with an increase in CVR [9].
Studies on age-related effects on the level of
FA and lipid profile were performed by Lin [10]
and Rise´; [11]. They have shown an increase in the
levels of EPA and DHA, starting with childhood,
among adults and the elderly, among both genders.
Otsuka with the co-authors [12, 13] found a posi-
tive correlation between age and absolute concen-
trations of EPA and DHA among adults aged 40-79
years. Harris with the co-authors [14] analyzed the
state of erythrocytes among 160 000 patients who
were determined CVR and found an increase in
relative levels of EPA and DHA.
Rajalahti with the co-authors [15] showed that
for individuals of both genders, absolute concentra-
tions of EPA and DHA increase beginning from pre-
pubertal age to adulthood (up to 40 years). Among
women, this process continues with age (EPA and
DHA continues to increase) and continues even
in the elder age, while there is no such tendency
among men. At the same time, it was revealed, that
among males with age (from prepubertal up to adult
age) the concentrations of most of the fatty acids
increased with 16-18 carbon atoms, although there
was no such tendency in women.
The objective of the study. To reveal the age
peculiarities of the fat-acidic and lipid plasma spec-
trum of blood in the inhabitants with overweight
and obesity of the plain inhabited localities in the
Transcarpathian region.
1. Materials and Methods
There were examined 107 persons who applied for
assistance to the Family Medicine Outpatient Clinic
#7 in Uzhgorod. The following persons were evalu-
ated for the next data: age, gender, BMI, waist cir-
cumference, indeces of lipid spectrum (total choles-
terol levels (TCL), low density lipoprotein choles-
terol (LDL cholesterol), high density lipoprotein
cholesterol (HDL cholesterol), triglycerides (TG),
coefficient of atherogenicity (CA)), levels of sat-
urated FA (myristinic acid (14:0), pentadecanoic
acid of FA (15:0), stearinic acid of FA (18:0), palmi-
tinic acid (16:0)), monounsaturated FA (palmitoleic
acid (16:1), oleinic acid FA (18:1)), polyunsatu-
rated FA, in particular ω6 PUFA (linoleic acid
(18:2), γ-linolenoic (γ-18:3), digomo-γ-linolenoic
(γ-20:3), adrenic (22:4), docosapentaenoic (22:5),
arachidonic (20:4), and ω3 PUFA (α-linolenoic (α-
18:3), eicosapentaenoic (20:5) and docosahexaenoic
(22:6)).
Determination of the parameters of lipid metabo-
lism was performed using the spectrophotometric
method on the basis of the laboratory department
of the ”Gemo Medica” clinic (Uzhhorod, Ukraine),
using SIEMENS Dimension RxL Max apparatus.
Determination of the fatty acid composition of
the plasma was carried out using gas chromatogra-
phy. There were used an analytical gas chromato-
graph Varian 3900 (USA) and a quartz capillary
column with an immobilized phase Supelkovaks-
10 (15 x 0.25 mm x 0.25 µm, manufactured by
SUPELKO, Switzerland) to study the fatty acid
composition of the plasma.
In the course of performance of the examination
of patients, we’ve used international and Ukrainian
regulatory medical ethics documents, namely: the
Geneva Declaration, the Helsinki Declaration, the
International Code of Medical Ethics, International
Guidance on the Ethics of Biomedical Research on
Human Personality, CIOMS (Geneva, 1993), Dec-
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laration on Patient Care in Europe, World Health
Organization (1994), ICH GCP. Involvement of the
patient into the study was carried out only with the
signature of his/her voluntary individual informed
consent.
Statistical data processing, in particular the de-
termination of the T-test and the Pearson rank-corre-
lation coefficient, was performed using the ”Mi-
crosoft Excel 2013” software.
2. Results and Discussion
The study involved 74 women (69.1%) and 33 men
(30.9%). The average age of the examined persons
was 52.4±1.0 years. The BMI of the examined pa-
tients was 27.5±0.4 kg/m2, the waist circumference
was 92.4±1.6 cm. Among the concomitant pathol-
ogy, arterial hypertension was prevalent in 35.1%
of the patients, the angina pectoris was recorded
in 5.4%, BMI in anamnesis – in 4.1%, type 2 DM
was observed in 4.1% of people. The complicated
hereditary history of cardiovascular diseases was in
39.2%; 29.8% of the studied persons were smokers
at the time of the research, 6.8% smoked in the past,
63.5% did not smoke at all.
The mean values of TCL were 5.08±0.1 mmol/l,
LDL cholesterol 3.3±0.08 mmol/l, HDL choles-
terol 1.31±0.02 mmol/l, TG 1.55±0.08 mmol/l,
and CA 2.97±0.1.
The total level of all PUFAs was 1443.1±34.4
µg/ml, of whichω6-PUFA was 1349.1±32.1 µg/ml,
and ω3-PUFA was 94.0±3.7 µg/ml.
All patients were divided into the following age
groups: up to 40 years (subgroup 1), 41-45 years
(subgroup 2), 46-50 years (subgroup 3), 51-55 years
(subgroup 4), 56-60 years (subgroup 5), 61-65 years
(subgroup 6).
When comparing these age groups, there is a
tendency of BMI increase from 24.80±1.10 kg/m2
in subgroup 1 to 26.05±1.90 kg/m2 in subgroup 2
(p=0.58), starting from age of 46 years and older,
in each age group, there was a significantly higher
BMI compared with the subgroup 1: 27.80±1.10
kg/m2 in subgroup 3 (p=0.05), 28.90±1.20 kg/m2
in subgroup 4 (p<0.01), 28.70±1.10 kg/m2 in sub-
group 5 (p<0.01), 28.80±1.40 kg/m2 in subgroup 6
(p<0.01). According to the data of theInstitute for
Health Metrics and Evaluation, most people with
obesity were found in the age of 50-70 years [16].
Regarding indicators of lipid metabolism, in the
subgroup of persons younger than 40 years, normal
lipidograms were found: TCL – 3.95±0.16 mmol/l,
LDL cholesterol 2.60±0.12 mmol/l, HDL choles-
terol 1.21±0.07 mmol/l, TG 1.67±0.23 mmol/l. In
each of the following age groups, there were signif-
icantly higher levels of both TCL and LDL choles-
terol compared to the subgroup of persons under 40
years of age (see Table 1).
At the same time, there were no significant dif-
ferences in the parameters of TCL, LDL choles-
terol between subgroups 2-6. There were no age
differences between the mean levels of HDL choles-
terol and triglycerides in any of the six subgroups
compared. Thus, in the examined patients over 40
years of age, changes in the lipid spectrum are ob-
served in the direction of growth of atherogenic frac-
tions. Although there is no significant difference
between subgroup 1 and subgroup 2 in relation to
BMI, persons in the second subgroup have already
had atherogenic changes in the lipid spectrum. The
study involved 1058 residents of Barnaul; it was
found that levels of TCL and LDL cholesterol are
believed to increase in persons over 30 years of age,
regardless of gender [17].
When comparing the fat-acidic composition of
plasma of patients in the 1 and 2 age subgroups,
no significant differences were found regarding the
total level of saturated fatty acids. At the same time,
differences in the levels of the individual ω3-PUFA
and ω6-PUFA were revealed. In patients aged 41-
45 years, compared with individuals under the age
of 40 years, significantly higher levels of oleinic FA
were detected (18:1, 573.40±51.80 µg/ml against
412.70±50.20 µg/ml, p=0.04), linoleic acid (18:2,
1001.70±44.70 µg/ml versus 835.90±48.10 µg/ml,
p=0.02), arachidonic FA (20:4, 221.30±14.10 µg/ml
against 172.40±10.20 µg/ml, p=0.01), eicosapen-
taenoic acid (20:5, 12.80±1.40 µg/ml versus
7.90±1.40 µg/ml, p=0.03), docosapentaenoic (22:5,
12.70±1.40 µg/l against 8.30±0.70 µg/ml, p=0.02)
and docosahexaenoic acids (22:6, 53.80±5.20 µg/ml
versus 38.30±3.50 µg/ml, p=0.03). According
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Table 1. Age peculiarities of lipid spectrum indices
Subgroup Age limits TCL, mmol/l p LDL cholesterol,
mmol/l
p
1 under 40 years 3.94±0.16 2.60±0.12
2 41-45 years 5.38±0.28 <0.01 3.47±0.21 <0.01
3 46-50 years 4.95±0.24 <0.01 3.15±0.19 <0.01
4 51-55 years 5.57±0.25 <0.01 3.60±0.22 <0.01
5 56-60 years 5.36±0.19 <0.01 3.51±0.19 <0.01
6 61-65 years 5.31±0.32 <0.01 3.39±0.27 =0.01
to the data of the Japanese population study [10],
serum EPA and DHA increased, while levels of
arachidonic acid decreased with age, and remained
unchanged even after adjusting for intake of fatty
acids. It was found that levels of EPA and EPA/arachidonic
acid ratio compared with DHA levels correlate more
strongly with those subgroups of lipoproteins asso-
ciated with CVR decrease, but this is more pro-
nounced in women and less in men [10].
The average level of totalω3-PUFA in subgroup
2 was 1.46-fold higher than that one of subgroup
1 (87.60±7.20 µg/ml versus 60.10±5.50 µg/ml,
p<0.01) , whereas the ω6-PUFA level was 1.22-
fold higher (1288.10±62.40 µg/ml versus
1056.30±60.10 µg/ml, p=0.02). When comparing
the fat-acidic profile of subgroup 2 and subgroup
3, there is an increase of the total level of PUFA
1.17-fold from 1375.70±63 µg/ml to 1604±74.60
µg/ml (p=0.03) due to ω6-PUFA, which is per-
formed at the expense of ω6-PUFA, the level of
which in the subgroup 2 was 1288.10 62.40 µg/ml,
and in the subgroup 3 – 1501.10±67.50 µg/ml
(p=0.03).
Beginning from 46 years (subgroups 3-6), the
levels of total ω6-PUFA and ω3-PUFA are sig-
nificantly higher than those in persons under 40
years of age (Fig. 1). In people under 50 years of
age there is an increase of average levels of PUFA,
though the highest growth of ω3 PUFA was ob-
served in the period from 40 to 50 years, and ω6
PUFA in the period from 45 to 50 years. There
were no significant differences in the comparison
of subgroups 3, 4, 5 and 6 with the respect to the
average levels of higher fatty acids. This indicates a
stabilization of the fat-acidic composition of blood
after 50 years.
There were revealed significantly higher levels
of individual ω6 and saturated FA in subgroup 3:
γ-linolenic FA (γ-18:3, 16.50±2 vs. 10.80±1.10
µg/ml, p=0.02), digomo-γ-linolenic (γ-20:3, 42.30
±3.30 vs. 31.10±2.90 µg/ml, p=0.02), arachi-
donic (20:4, 272.30±16 vs. 221.30±14.20 µg/ml,
p=0.02), stearic (18:0, 241.70±34.70 vs. 157.90
±16.40 µg/ml, p=0.02) and linoleic FA (18:2,
1149.70±56 versus 1001.70±44.70 µg/ml, p=0.04).
Patients aged 41 to 45 have significantly lower
levels of stearic (18:0), γ-linolenic (γ-18:3) and
digomo-γ-linolenic FA (γ-20:3) compared to those
in subgroups 3-6 (see Table 2). According to the
data of another Japanese study, the concentration
of arachidonic acid in blood serum increased dur-
ing 4 years in both men and women aged 40-69,
even after adjusting of intake of arachidonic acid
[13]. Higher levels of DHA and lower EPA levels
in young women are consistent with an elevated
conversion of EPA to DHA during the reproductive
age [14].
3. Conclusions
In the examined persons over 40 years of age there
is a change in the lipid spectrum, which corresponds
to atherogenic dyslipidemia.
In individuals under 50 years of age there is an
increase of total levels of PUFA, with the highest
growth of ω3-PUFA which was observed in the
period from 40 to 50 years, and ω6-PUFA in the pe-
riod from 45 to 50 years. After 50 years of age, the
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Figure 1. Total levels of polyunsaturated fatty acids in different age groups
stabilization of the fatty acid composition occurs.
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